NRG-BR008, "A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer" (HERO)

Is This Study For You?

Let's Get Started!

Details
Age
Adult
Locations

Greeley Campus
Harmony Campus
Highlands Ranch Hospital
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital

Principal Investigator
Photograph of Rachel Rabinovitch

Rachel Rabinovitch

Study ID

Protocol Number: 23-0798

More information available at ClinicalTrials.gov: NCT05705401

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers